A recent study showed that skin equivalents composed of 11 and 15% CRISPR/Cas9-gene corrected KCs and fibroblasts, respectively, resulted in 26% C7 re-expression and AF formation in vivo (Izmiryan et al., 2018). Here, TBCE is linked to atrial fibrillation.